Last reviewed · How we verify
NCT06953180
Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction
trial testing Genetic: DNA analysis in Cardiovascular Diseases (CVD) in 6,720 participants. Currently enrolling.
1 January 2026
Quick facts
| Lead sponsor | Asfendiyarov Kazakh National Medical University |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 6,720 |
| Start date | 3 March 2025 |
| Primary completion | 1 January 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across Kazakhstan |
Drugs / interventions tested
- Genetic: DNA analysis
Conditions studied
- Cardiovascular Diseases (CVD) — all drugs for Cardiovascular Diseases (CVD) →
- Type 2 Diabetes — all drugs for Type 2 Diabetes →
- Chronic Respiratory Diseases — all drugs for Chronic Respiratory Diseases →
- Obesity (Disorder) — all drugs for Obesity (Disorder) →
Sponsor
Asfendiyarov Kazakh National Medical University
Who can join
Adults 18 to 69, any sex, with Cardiovascular Diseases (CVD) or Type 2 Diabetes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to enhance personalized and preventive care for non-communicable diseases (NCDs) in Kazakhstan by examining epigenetic factors, predicting biological age and reproductive function using machine learning, and developing health improvement recommendations.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Vaccination Attitudes in the Adult Population of Kazakhstan: A Nationally Representative Cross-Sectional Study.
Ismoldayev Y, Ibrayeva A, Izdenov A, Lee S, et al · · 2026 · PMID 42042829 · DOI 10.3390/vaccines14040353
Verify or expand the search:
- PubMed search for NCT06953180
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cardiovascular Diseases (CVD)
Currently open trials in the same condition.
- NCT07133516 — A Multi-center Study on Artificial Intelligence-Based Quantitative Evaluation of Echocardiography · recruiting
- NCT07043166 — Cardiovascular-Kidney-Metabolic Syndrome in Shanghai Zicitizens · recruiting
- NCT07248371 — Validating Integrative Multi-omics Approaches in Metabolic Syndrome-related Diseases · recruiting
- NCT07025590 — Effect of Exercise on Tapering Antipsychotics in Patients With Psycho-cardiological Disease(EXTRA-study) · NA · recruiting
- NCT06903559 — Roxadustat's Effect on Heart, Nutrition, and Inflammation in Hemodialysis Patients · Phase 1, PHASE2 · recruiting
Other Asfendiyarov Kazakh National Medical University trials
Trials by the same sponsor.
- NCT06496022 — Comparative Analysis of Risk Factors and Prediction of Frailty Syndrome · active not recruiting
- NCT05970861 — Effect of Natural Food on Gut Microbiome and Phospholipid Spectrum of Immune Cells in COVID-19 Patients · NA · completed
- NCT05095155 — Study of the Prognostic Role of Gene Polymorphism in the Development of B-cell Leukemias and Lymphomas in Children of Ka · completed
- NCT05090644 — Program for the Introduction Into Clinical Practice of the Principles of Personalized and Preventive Medicine Based on t · completed
- NCT05088486 — The Role of Genetic Factors in the Development of Arterial Hypertension in the Kazakh Population · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06953180 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Asfendiyarov Kazakh National Medical University
- Last refreshed: 11 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06953180.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing